Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia.

Journal of clinical lipidology - 1 Jan 2000

Brown Emily E, Byrne Kathleen H, Davis Dorothy M, McClellan Rebecca, Leucker Thorsten, Jones Steven R, Martin Seth S

Abstract excerpt

BACKGROUND: It is estimated that less than 10% of cases of familial hypercholesterolemia (FH) in the United States have been diagnosed. Low rates of diagnosis may in part be attributable to affected patients not meeting the clinical diagnostic criteria of the Dutch Lipid Clinic Network (DLCN), Simon Broome, or US MEDPED diagnostic criteria. OBJECTIVE: The objective of this study was to assess the utility of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Testing
Share to Hyperlipoproteinemia Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Registries

Share to Risk Factors

Share to Young Adult

Source

Identifiers

PMID: 32220565
DOI: 10.1016/j.jacl.2020.02.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia.PMID 32220565Read ↗

The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.Semantic proximity Read ↗

Genetic testing for familial hypercholesterolemiaSemantic proximity Read ↗

Beyond the Usual Suspects: Expanding on Mutations and Detection for Familial Hypercholesterolemia.Semantic proximity Read ↗

Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare SystemSemantic proximity Read ↗

The Spectrum of Genetic Causes of Familial Hypercholesterolemia Phenotype.Semantic proximity Read ↗

Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.Semantic proximity Read ↗

Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes?Semantic proximity Read ↗

The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification.Semantic proximity Read ↗

Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the NetherlandsSemantic proximity Read ↗

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia DiagnosisSemantic proximity Read ↗

Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.Semantic proximity Read ↗

Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.